Immune cell infiltration in head and neck squamous cell carcinoma and patient outcome: a retrospective study

被引:47
|
作者
Schneider, Karolin [1 ]
Marbaix, Etienne [2 ,3 ]
Bouzin, Caroline [4 ]
Hamoir, Marc [5 ]
Mahy, Pierre [6 ]
Bol, Vanesa [1 ]
Gregoire, Vincent [1 ,7 ]
机构
[1] Catholic Univ Louvain, Ctr Mol Imaging Radiotherapy & Oncol MIRO, Inst Expt & Clin Res IREC, Brussels, Belgium
[2] St Luc Univ Hosp, Dept Pathol, Brussels, Belgium
[3] Catholic Univ Louvain, de Duve Inst, Cell Biol Unit, Brussels, Belgium
[4] Catholic Univ Louvain, Inst Expt & Clin Res IREC, IREC Imaging Platform, Brussels, Belgium
[5] St Luc Univ Hosp, King Albert II Canc Inst, Dept Otorhinolaryngol & Head & Neck Surg, Brussels, Belgium
[6] St Luc Univ Hosp, King Albert II Canc Inst, Dept Stomatol & Maxillofacial Surg, Brussels, Belgium
[7] St Luc Univ Hosp, King Albert II Canc Inst, Dept Radiat Oncol, Brussels, Belgium
关键词
HUMAN-PAPILLOMAVIRUS; OROPHARYNGEAL CANCER; LYMPHOCYTES; PREVALENCE; PROGNOSIS; SURVIVAL; MARKERS; TUMORS;
D O I
10.1080/0284186X.2018.1445287
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Human papillomavirus (HPV) prevalence in oropharynx squamous cell carcinoma (OPSCC) is on the rise. HPV-linked OPSCCs represent a distinct clinical entity with a better treatment response and patient survival compared to tumors not linked to HPV. An emerging role in treatment response has been attributed to immune cell infiltration in human tumors. In this study, we investigated immune cell infiltration in human SCC of the head and neck region and its relation to overall survival after treatment with surgery (with or without radiotherapy) or concomitant chemo (or cetuximab)-radiotherapy. Materials and methods: Paraffin-embedded tumor samples of 136 patients with SCC of the larynx, hypopharynx, oral cavity and oropharynx were processed for immunohistochemical detection of CD3(+) T-cells, CD8(+) cytotoxic T-cells, CD20(+) B-cells and CD163(+) M2 macrophages within the tumor infiltrated area. Clinico-pathological data were analyzed as a function of tumor location and p16-status. Immune cell infiltration was represented as stained area on the whole tumor infiltrated area, compared for the different tumor locations and correlated to patient survival. Results: Patients with oropharynx tumors expressing significant p16 levels (p16-sg) had a 5-year overall survival of 85% compared to 43% for patients with no significant p16 (p16-ns) expression (HR: 0.3 - 95% CI: 0.1-0.6). Median immune cell infiltration (T- and B-lymphocytes) was significantly elevated in p16-sg oropharyngeal tumors, compared to p16-ns oropharyngeal tumors and to all other head and neck tumor locations. No difference in CD163(+) macrophage infiltration was observed across the different patient groups. In the whole population, a high infiltration by CD3(+) T-lymphocytes was associated to a significantly (p=.03; HR: 0.6, 95% CI: 0.4-0.97) better overall survival. Conclusion: Oropharynx cancer with significant p16 expression showed an increased overall survival and elevated T- and B-lymphocyte infiltration, which suggests a prognostic relevance of immune cell infiltration.
引用
收藏
页码:1165 / 1172
页数:8
相关论文
共 50 条
  • [21] Comprehensive analysis of significant genes and immune cell infiltration in HPV-related head and neck squamous cell carcinoma
    Xu, Lei
    Jin, Yu
    Qin, Xing
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 87
  • [22] Identification of ETV4 as a prognostic biomarker and correlates with immune cell infiltration in head and neck squamous cell carcinoma
    Yulian Tang
    Wenyu Xie
    Ting Hu
    Changqiao Huang
    Wenli Yin
    Sijing Wei
    Fengming Lai
    Lizhu Tang
    Scientific Reports, 15 (1)
  • [23] Tumor-infiltrating immune cells and survival in head and neck squamous cell carcinoma: a retrospective computational study
    Zhang, Lei
    Wang, Wei-Quan
    Chen, Jun-Hong
    Feng, Jia
    Liao, Ya-Zhou
    Zou, You
    Liu, Rong
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [24] Predictive Role of NEK6 in Prognosis and Immune Infiltration in Head and Neck Squamous Cell Carcinoma
    Yang, Zhi-Min
    Liao, Bing
    Yang, Si-Si
    Su, Tong
    Zhang, Jing
    Wang, Wei-Ming
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [25] PRF1 is a prognostic marker and correlated with immune infiltration in head and neck squamous cell carcinoma
    Fan, Cui
    Hu, Haixia
    Shen, Yilin
    Wang, Quan
    Mao, Yufeng
    Ye, Bin
    Xiang, Mingliang
    TRANSLATIONAL ONCOLOGY, 2021, 14 (04):
  • [26] TYK2 correlates with immune infiltration: A prognostic marker for head and neck squamous cell carcinoma
    He, Yaodong
    Li, Yunshan
    Xiang, Junwei
    Huang, Xu
    Zhao, Mingyu
    Wang, Yuanyin
    Chen, Ran
    FRONTIERS IN GENETICS, 2022, 13
  • [27] Effect of cancer-associated fibroblasts on prognosis and immune infiltration in head and neck squamous cell carcinoma
    Xu, Yuan-yuan
    Zhu, Huanfeng
    Zong, Dan
    Qian, Luxi
    Cai, Yi
    Xiang, Nan
    PRECISION MEDICAL SCIENCES, 2024, 13 (02): : 118 - 129
  • [28] CTHRC1 is a prognostic biomarker correlated with immune infiltration in head and neck squamous cell carcinoma
    Zhang, Zhichao
    Ren, Xusheng
    Wang, Yiling
    Liu, Ping
    Lin, Peng
    Jin, Shumei
    Xu, Chao
    BMC ORAL HEALTH, 2024, 24 (01):
  • [29] Deciphering COPS5 influence on immune infiltration and prognosis in head and neck squamous cell carcinoma
    Wan, Yuhang
    Wang, Dujuan
    Yang, Gui
    Liu, Guohong
    Pan, Yunbao
    HELIYON, 2024, 10 (13)
  • [30] Increased Expression of PDGFA Is Associated With Poor Prognosis and Immune Infiltration in Head and Neck Squamous Cell Carcinoma
    Wang, Kaiqin
    Li, Changya
    Chen, Huarong
    Gu, Ping
    Lu, Jiafeng
    Zhao, Houyu
    Zhuo, Xianlu
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2024, 53 (09) : 584 - 594